The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B
Open accessAbstract
Transcription factors of the NF-kappaB/Rel family are critical for inducible expression of multiple genes involved in inflammatory responses. Sulfasalazine and its salicylate moiety 5-aminosalicylic acid are among the most effective agents for treating inflammatory bowel disease and rheumatoid arthritis. However, the mode of action of these drugs remains unclear. Here we provide evidence that the transcription factor NF-kappaB is a target of sulfasalazine-mediated immunosuppression. Treatment of SW620 colon cells with sulfasalazine inhibited TNFalpha-, LPS-, or phorbol ester- induced NF-kappaB activation. NF-kappaB-dependent transcription was inhibited by sulfasalazine at micro- to millimolar concentrations. In contrast, 5-aminosalicylic acid or sulfapyridine did not block NF-kappaB activation at all doses tested. TNFalpha-induced nuclear translocation of NF-kappaB was prevented by sulfasalazine through inhibition of IkappaBalpha degradation. When blocking proteasome-mediated degradation of IkappaBalpha, we could demonstrate that sulfasalazine interfered with IkappaBalpha phosphorylation, suggesting a direct effect on an IkappaBalpha kinase or on an upstream signal. Inhibition of NF-kappaB activation seems to be specific since other DNA-binding activities such as AP1 were not affected. These results demonstrate that sulfasalazine is a potent and specific inhibitor of NF-kappaB activation, and thus may explain some of the known biological properties of sulfasalazine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intriguingly, sulfasalazine, a drug used for decades to treat autoimmune inflammatory bowel disease (IBD) and psoriatic arthritis (Gupta et al., 1990), is now recognized as targeting the BH4 pathway by inhibiting SPR (Haruki et al., 2013), in addition to other targets, such as NFκB (Wahl et al., 1998).”
From The Role of Iron Regulation in Immunometabolism and Immune-Related Disease (2019) · cites this paper as Wahl et al., 1998
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Schreck, R., RIEBER, P., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07761.x · Cited by 3,793
Baeuerle, P. A., & Baltimore, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81318-5 · Cited by 3,002
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
Palombella, V. J., Rando, O. J., Goldberg, A. L., & Maniatis, T. (1994) · Cell · doi:10.1016/s0092-8674(94)90482-0 · Cited by 2,089
Structure, Regulation and Function of NF-kappaB
Siebenlist, U. K., Franzoso, G., & Brown, K. D. (1994) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.10.110194.002201 · Cited by 2,086
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E. B., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,744
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,676
Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.
Schreck, R., Meier, B., Männel, D. N., Dröge, W., & Baeuerle, P. A. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1181 · Cited by 1,508
Control of IκB-α Proteolysis by Site-Specific, Signal-Induced Phosphorylation
Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., & Siebenlist, U. (1995) · Science · doi:10.1126/science.7878466 · Cited by 1,434
Research works printed but not linked: 1
- [34]34. Chiao, P.J., M. Shigeki, and I.M. Verma. 1994. Autoregulation of I k B a activity. Proc. Natl. Acad. Sci. USA. 91:28-32.
Cited by
Sorted by citations
Items 401–500 of 743
Inflammation and Gastrointestinal Cancers
Jankowski, J. A. (2011) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-03503-6 · Cited by 24
Anti-Inflammatory Therapies for Treatment of Inflammation-Related Preterm Brain Injury
Prasad, J. D., Gunn, K. C., Davidson, J. O., Galinsky, R., Graham, S. E., Berry, M. J., Bennet, L., Gunn, A. J., & Dean, J. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084008 · Cited by 23
Transcription factors in autoimmune diseases
Stanford, L. P. (2008) · Frontiers in bioscience · doi:10.2741/3001 · Cited by 24
Haddad, J. J., & Land, S. C. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5172 · Cited by 24
Increased nuclear factor-kappaB activation in colitis of interleukin-2-deficient mice
Yang, F., de Villiers, W. J. S., Lee, E. Y., McClain, C. J., & Varilek, G. W. (1999) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(99)90152-x · Cited by 24
Pharmacologic approaches to amino acid depletion for cancer therapy
Wilder, C. S., Chen, Z., & DiGiovanni, J. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23349 · Cited by 23
Rosell-Hidalgo, A., Moore, A. L., & Ghafourian, T. (2022) · Toxicology · doi:10.1016/j.tox.2022.153412 · Cited by 24
Chávez, E., Castro‐Sánchez, L., Shibayama, M., Tsutsumi, V., MORENO, M., & Muriel, P. (2012) · Human & Experimental Toxicology · doi:10.1177/0960327112438928 · Cited by 23
Oligonucleotide Therapies in the Treatment of Arthritis: A Narrative Review
Wijesinghe, S. N., Lindsay, M. A., & Jones, S. W. (2021) · Biomedicines · doi:10.3390/biomedicines9080902 · Cited by 23
Smallwood, H. S., Shi, L., & Squier, T. C. (2006) · Biochemistry · doi:10.1021/bi060485p · Cited by 23
Translocation of Nuclear Factor-κB on Corneal Epithelial Cells Induced by Ultraviolet B Irradiation
Lee, D., Kim, J. K., & Joo, C. (2005) · Ophthalmic Research · doi:10.1159/000084249 · Cited by 23
Giannini, E. G., Kane, S., Testa, R., & Savarino, V. (2005) · Digestive and Liver Disease · doi:10.1016/j.dld.2005.02.012 · Cited by 23
Hübinger, G., Schneider, C., Stöhr, D., Ruff, H., Kirchner, D., Schwänen, C., Schmid, M., Bergmann, L., & Müller, E. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.01.003 · Cited by 23
Sulfasalazine inhibits reperfusion injury and prolongs allograft survival in rat cardiac transplants
Feeley, B. T., Park, A. K., Hoyt, E. G., & Robbins, R. C. (1999) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(99)00078-9 · Cited by 23
Haddad, J. J. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00213-9 · Cited by 23
Cytokine-based therapies in inflammatory bowel disease
Kam, L. Y., & Targan, S. R. (1999) · Current Opinion in Gastroenterology · doi:10.1097/00001574-199907000-00005 · Cited by 23
NF-κB Blockade Reduces the O 2 -Evoked Rise in Na + Conductance in Fetal Alveolar Cells
Haddad, J. J., Collett, A., Land, S. C., Olver, R. E., & Wilson, S. M. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4453 · Cited by 23
ORIGINAL ARTICLE: Can Sulfasalazine Prevent Infection‐Mediated Pre‐Term Birth in a Murine Model?
Nath, C. A., Ananth, C. V., Smulian, J. C., & Peltier, M. R. (2009) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2009.00773.x · Cited by 22
Zhou, Q., Zhang, Q., Wang, K., Huang, T. H., Deng, S., Wang, Y., & Cheng, C. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106181 · Cited by 22
Taurochenodeoxycholic acid induces apoptosis of fibroblast-like synoviocytes
Li, L., Liu, C., Liu, M., Shi, L., Liu, Q., Guan, H., & Li, P. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.02.051 · Cited by 22
Dirlik, M., Karahan, A., Canbaz, H., Çağlıkülekçi, M., Polat, A., Tamer, L., & Aydın, S. (2009) · Current Therapeutic Research · doi:10.1016/j.curtheres.2009.08.005 · Cited by 22
Transcriptomic analysis reveals the mechanism of sulfasalazine-induced liver injury in mice
Li, Y., Shen, J.-D., Lu, S., Zhu, L.-L., Wang, B., Bai, M., & Xu, E. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.12.011 · Cited by 22
Bourreille, Segain, de la Blétière, R., Siavoshian, Vallette, Galmiche, & Blottière (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00410.x · Cited by 22
The buried bumper syndrome: a complication of percutaneous endoscopic gastrostomy
Sheers, R., & CHAPMAN, S. (1998) · Gut · doi:10.1136/gut.43.4.586a · Cited by 22
Bafutto, M., de Almeida, J. R., Leite, N. V., Costa, M. B., de Oliveira, Ê. C., & RESENDE-FILHO, J. (2013) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032013000400012 · Cited by 22
The Clinical Application of Ozonetherapy
Bocci, V. A. (2010) · Springer eBooks · doi:10.1007/978-90-481-9234-2_9 · Cited by 24
Hassan, M. H., & Ghobara, M. (2016) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-016-1263-1 · Cited by 21
Sambuelli, A. M., Diez, R. A., Sugai, E., Boerr, L. A., Negreira, S., Gil, Á., Camartino, G., Huernos, S. P., Doldan, I., Felstiner, D., et al. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00861.x · Cited by 21
Lakey, R., & Cawston, T. E. (2009) · Lara D. Veeken · doi:10.1093/rheumatology/kep236 · Cited by 21
Sulfasalazine reduces inflammatory renal injury in unilateral ureteral obstruction
Demi̇rbi̇lek, S., Emre, M. H., Aydın, N. E., Edalı, M. N., Aksoy, R. T., Akın, M., Gürünlüoğlu, K., Taş, E., Ay, S., & Yılmaz, Z. (2007) · Pediatric Nephrology · doi:10.1007/s00467-006-0416-8 · Cited by 21
Role of nuclear factor-κB in interleukin-1-induced collagen degradation by corneal fibroblasts
Lu, Y. Y., Fukuda, K., Li, Q., Kumagai, N., & Nishida, T. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.02.008 · Cited by 21
Gandia, P., Idier, I., & Houin, G. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006296522 · Cited by 21
Sulfasalazine reduces bile acid induced apoptosis in human hepatoma cells and perfused rat livers
Rust, C., Bauchmuller, K., Bernt, C., Vennegeerts, T., Fickert, P., Fuchsbichler, A., & Beuers, U. (2006) · Gut · doi:10.1136/gut.2005.077461 · Cited by 20
de Jong, P. H. P., Quax, R. A. M., Huisman, M., Gerards, A., Feelders, R. A., de Sonnaville, P. B., Luime, J. J., Weel, A. E. A. M., & Hazes, J. M. W. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202152 · Cited by 20
Thomas, A. G., Sattler, R., TenDyke, K., Loiacono, K. A., Hansen, H. F., Sahni, V., Hashizume, Y., Rojas, C. J., & Slusher, B. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127785 · Cited by 20
Kim, W., Nam, J., Lee, S., Jeong, S., & Jung, Y. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00294 · Cited by 20
Oshima, T., Pavlick, K. P., Grisham, M. B., Jordan, P., Manas, K. J., Joh, T., Itoh, M., & Alexander, J. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01048.x · Cited by 20
Cystathionine-γ-lyase drives antioxidant defense in cysteine-restricted IDH1-mutant astrocytomas
Cano-Galiano, A., Oudin, A., Fack, F., Allega, M. F., Sumpton, D. P., Martínez-García, E., Dittmar, G., Hau, A., Falco, A. D., Herold‐Mende, C. C., et al. (2021) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdab057 · Cited by 19
Wang, W., Ning, Y., Wang, Y., Deng, G., Pace, S., Barth, S., Menge, C., Zhang, K., Dai, Y., Cai, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.849583 · Cited by 20
Kaul, D. K., Kollander, R., Mahaseth, H., Liu, X. D., Solovey, A. N., Belcher, J. D., Kelm, R. J., Vercellotti, G. M., & Hebbel, R. P. (2006) · Microcirculation · doi:10.1080/10739680600778456 · Cited by 19
Yu, H.-C., Lu, M., Huang, K., Huang, H.-L., Liu, S.-Q., Huang, H.-B., & Lai, N. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms17010046 · Cited by 19
Figuera-Losada, M., Thomas, A. G., Stathis, M. J., Stockwell, B. R., Rojas, C. J., & Slusher, B. S. (2017) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2016.12.009 · Cited by 18
Inhibitors of NF-κB derived from thalidomide
de Blanco, E. J. C., Pandit, B., Hu, Z., Shi, J., Lewis, A., & Li, P. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.01.088 · Cited by 19
Glycoprotein Isolated from Solanum nigrum L. Kills HT-29 Cells Through Apoptosis
Lim, K. (2005) · Journal of Medicinal Food · doi:10.1089/jmf.2005.8.215 · Cited by 19
Hermisson, M., & Weller, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401269 · Cited by 19
Ferroptosis in Ischemic Stroke and Related Traditional Chinese Medicines
Ma, R., Sun, X., Liu, Z., Zhang, J., Yang, G., Tian, J., & Wang, Y. (2024) · Molecules · doi:10.3390/molecules29184359 · Cited by 20
Gupta, R., Mehra, N. K., & Jain, N. K. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.10.018 · Cited by 18
Lee, D. H., Cho, K. S., Park, S., Kim, E. K., & Joo, C.-K. (2005) · Journal of Cataract & Refractive Surgery · doi:10.1016/j.jcrs.2004.05.053 · Cited by 18
Chronic hypoxia up-regulates expression of adenosine A1 receptors in DDT1-MF2 cells
Hammond, L. C., Bonnet, C., Kemp, P. J., Yates, M. S., & Bowmer, C. J. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.09.003 · Cited by 18
Um, H.-R., Lim, W., Chae, S., Park, S., Park, J. H., & Cho, H. (2006) · Virus Research · doi:10.1016/j.virusres.2006.11.007 · Cited by 18
Transcription factors in the pathogenesis of autoimmunity
Peng, S. L. (2004) · Clinical Immunology · doi:10.1016/j.clim.2003.10.008 · Cited by 18
Oerlemans, R., Vink, J., Dijkmans, B. A. C., Assaraf, Y. G., van Miltenburg, M., van der Heijden, J., Ifergan, I., Lems, W. F., Scheper, R. J., Kaspers, G. J. L., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.060509 · Cited by 18
Medeiros, R., Cabrini, D. A., & Calixto, J. Β. (2001) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00186-5 · Cited by 18
Handel, M. L., & Girgis, L. (2001) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2001.0186 · Cited by 18
The Regulation Role of Ferroptosis Mechanism of Anti-Cancer Drugs and Noncoding RNAs
Ensoy, M., Bumin, Z. S., Jama, H. A., & Cansaran‐Duman, D. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220629154418 · Cited by 17
Innate immune defence: NOD2 and autophagy in the pathogenesis of Crohn’s disease
Hruz, P. L., & Eckmann, L. (2010) · Swiss Medical Weekly · doi:10.4414/smw.2010.13135 · Cited by 18
Treatment of COVID-19 by Controlling the Activity of the Nuclear Factor-Kappa B
El-Khodary, M. S. M. (2020) · CellBio · doi:10.4236/cellbio.2020.92006 · Cited by 17
Sykes, L., Thomson, K., Boyce, E. J., Lee, Y. S., Rasheed, Z. B. M., MacIntyre, D. A., Teoh, T. G., & Bennett, P. R. (2015) · Immunology · doi:10.1111/imm.12534 · Cited by 17
Nandi, J., Saud, B., Zinkievich, J. M., Palma, D. T., & Levine, R. A. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9832-2 · Cited by 17
Lappas, M., Permezel, M., Ho, P. W. M., Moseley, J. M., Wlodek, M. E., & Rice, G. E. (2004) · Placenta · doi:10.1016/j.placenta.2004.02.003 · Cited by 17
de Bruin, M., Peters, G. J., Oerlemans, R., Assaraf, Y. G., Masterson, A. J., Adema, A. D., Dijkmans, B. A. C., Pinedo, H. M., & Jansen, G. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000315 · Cited by 17
Lee, S., Oh, J., Lee, M., Jang, M., Park, H., Kim, J., Min, D. S., Park, Y., Chang, Y., Bae, Y., et al. (2004) · European Journal of Immunology · doi:10.1002/eji.200425117 · Cited by 17
Wu, Y., & Zhu, B. T. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110366 · Cited by 16
Garmish, O., Smiyan, S., Hladkykh, F. V., Koshak, B., & Komorovsky, R. (2025) · Vascular Health and Risk Management · doi:10.2147/vhrm.s523939 · Cited by 17
Riva, D. A., Larrosa, P. N. F., Dolcini, G. L., Peralta, L. M., Coulombié, F. C., & Mersich, S. E. (2008) · Archives of Virology · doi:10.1007/s00705-007-0023-4 · Cited by 16
EFFICACY OF SULPHASALAZINE ON LUNG HISTOPATHOLOGY IN A MURINE MODEL OF CHRONIC ASTHMA
Ölmez, D., Babayiğit, A., Uzuner, N., Erbil, G., Karaman, Ö., Yılmaz, O., Çetin, E. Ö., & Özoğul, C. (2008) · Experimental Lung Research · doi:10.1080/01902140802271859 · Cited by 16
xCT/SLC7A11 antiporter function inhibits HIV-1 infection
Rabinowitz, J., Sharifi, H. J., Martin, H., Marchese, A. M., Robek, M. D., Shi, B., Mongin, A. A., & de Noronha, C. M. C. (2021) · Virology · doi:10.1016/j.virol.2021.01.008 · Cited by 17
Georgiev, V. S. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-297-1_45 · Cited by 16
Gupta, R., Mehra, N. K., & Jain, N. K. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1162-9 · Cited by 16
Jiang, G., Im, W. B., Donde, Y., & Wheeler, L. A. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.173252 · Cited by 16
Konson, A., Mahajna, J. A., Danon, A., Rimon, G., & Agbaria, R. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700983 · Cited by 16
Božić, B. D., Rogan, J., Poleti, D. D., Trišović, N. P., Nedeljković, B. B., & Uščumlić, G. (2012) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c12-00185 · Cited by 16
Lim, S., Suk, K., & Lee, W. (2013) · Cellular Immunology · doi:10.1016/j.cellimm.2013.08.002 · Cited by 16
Lee, S., Kim, E., Suk, K., & Lee, W. (2010) · Inflammation · doi:10.1007/s10753-010-9283-3 · Cited by 16
Sulfasalazine decreases astrogliosis‐mediated seizure burden
Alcoreza, O. B., Jagarlamudi, S., Savoia, A., Campbell, S. L., & Sontheimer, H. W. (2022) · Epilepsia · doi:10.1111/epi.17178 · Cited by 15
Slabáková, E., Hampl, A., Pernicová, Z., Staršíchová, A., Krčmář, P., Machala, M., Kozubı́k, A., & Souček, K. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.001 · Cited by 15
Dik, B., Bahçıvan, E., Faki, H. E., & Üney, K. (2018) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2017-0769 · Cited by 15
Weidenbach, H., Leiz, S., Nussler, A. K., Dikopoulos, N., Bachem, M. G., Buttenschoen, K., Reinshagen, M., Beger, H. G., Adler, G., & Schmid, R. M. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80238-x · Cited by 15
Self-citationHernández, M., de Arriba, A. F., Merlos, M., Fuentes, L., Crespo, M. S., & Nieto, M. L. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703820 · Cited by 15
Weber, T. J., Monks, T. J., & Lau, S. S. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.2.f270 · Cited by 15
Kim, S. Y., Tang, M., Lu, T., Chih, S. Y., & Li, W. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149045 · Cited by 17
Effect of Sulfasalazine on Renal Ischemia/Reperfusion Injury in Rats
Camara-Lemarroy, C. R., Garza, F., Alarcón-Galván, G., Cordero‐Pérez, P., & Fernández-Garza, N. E. (2009) · Renal Failure · doi:10.3109/08860220903151427 · Cited by 14
Sulfasalazine as an Immunomodulator of the Inflammatory Process during HIV-1 Infection
Feria, M. G., Rugeles, M. T., Hernández, J. C., Luján, J., & Taborda, N. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184476 · Cited by 14
Oxidative stress and cancer pain
Ungard, R. G., Seidlitz, E. P., & Singh, G. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0298 · Cited by 16
Hoy, Z., Wright, T. W., Elliott, M. R., Malone, J. E., Bhagwat, S. P., Wang, J., & Gigliotti, F. (2019) · Infection and Immunity · doi:10.1128/iai.00640-19 · Cited by 14
Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents
Infante, M., Padilla, N., Alejandro, R., Caprio, M., Della‐Morte, D., Fabbri, A., & Ricordi, C. (2022) · Medicina · doi:10.3390/medicina58050571 · Cited by 17
Tolerability of Aminosalicylates in Inflammatory Bowel Disease
Ishaq, S., & Green, J. R. (2001) · BioDrugs · doi:10.2165/00063030-200115050-00005 · Cited by 14
Lessons for inflammatory bowel disease from rheumatology
Rhodes, J., & COLLINS, P. D. (2005) · Digestive and Liver Disease · doi:10.1016/j.dld.2005.09.020 · Cited by 14
Laxer, R. M. (2005) · Elsevier eBooks · doi:10.1016/b978-1-4160-0246-8.50011-5 · Cited by 14
Maturation of human dendritic cells as sulfasalazine target.
Matasić, R., Dietz, A. B., & Vuk‐Pavlović, S. (2001) · PubMed · Cited by 14
Fratelli, M., Minto, M., Crespi, A., Erba, E., Vandenabeele, P., Soldato, P. D., & Ghezzi, P. (2003) · Antioxidants and Redox Signaling · doi:10.1089/152308603764816587 · Cited by 14
Dual role of the NF-κB transcription factor in the death of immature neurons
Castagné, V., Lefèvre, K., & Clarke, R. C. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00430-4 · Cited by 14
Ping, J., Gao, A.-M., Qin, H.-Q., Wei, X.-N., Bai, J., Liu, L., Li, X. H., Li, R.-W., Ao, Y., & Wang, H. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.179820 · Cited by 14
RetractedActivation of NFkappa B in inflammatory bowel disease Reply
Schmid, R. M., Adler, G., Liptay, S., Schreiber, S., Nikolaus, S., & Hampe, J. (1998) · Gut · doi:10.1136/gut.43.4.586c · Cited by 14
Self-citationCheng, H., Bao, X., Luo, Y.-Y., Li, Y.-H., Zhou, Y., Hua, Q., Qiu, Y.-J., Liang, X.-Y., Huang, Y., Liu, W., et al. (2024) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2024.106530 · Cited by 13
Kononoff, A., Vuolteenaho, K., Hämäläinen, M., Kautiainen, H., Elfving, P., Savolainen, E., Arstila, L., Niinisalo, H., Rutanen, J., Marjoniemi, O., et al. (2020) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000001412 · Cited by 13
Chemical hybridization of sulfasalazine and dihydroartemisinin promotes brain tumor cell death
Ackermann, A., Çapcı, A., Buchfelder, M., Tsogoeva, S. B., & Savaskan, N. E. (2021) · Scientific Reports · doi:10.1038/s41598-021-99960-z · Cited by 13
The levels of RAC3 expression are up regulated by TNF in the inflammatory response
Alvarado, C. V., Rubio, M. F., Larrosa, P. N. F., Panelo, L. C., Azurmendi, P. J., Grecco, M. R., Martínez-Noël, G. M. A., & Costas, M. A. (2014) · FEBS Open Bio · doi:10.1016/j.fob.2014.04.009 · Cited by 13
Immune Modulation as Adjunctive Therapy forPneumocystispneumonia
Wang, J., Wright, T. W., & Gigliotti, F. (2011) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2011/918038 · Cited by 13
Valentine, J. F. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.4.g1044 · Cited by 13
Metadata
- Authors
- Wahl, C., Liptay, S., Adler, G., & Schmid, R. M.
- Affiliations
- Universität Ulm (DE)
- Corresponding author
- Schmid, R M
- ORCID
- Schmid, R M
- Venue
- Journal of Clinical Investigation
- Published
- 1998-03-01
- Volume
- 101
- Issue
- 5
- Pages
- 1163-1174
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC508669
- OpenAlex
- W2011496352
- Cited by
- 742
- References
- 48
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 17 · 2023: 18 · 2022: 18 · 2021: 26 · 2020: 15 · 2019: 18 · 2018: 19 · 2017: 11 · 2016: 15 · 2015: 19 · 2014: 17 · 2013: 24 · 2012: 19
- FWCI
- 17.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- sulfasalazine, NF-κB, IκBα degradation, IκBα phosphorylation, IκBα kinase, NF-κB nuclear translocation, 5-aminosalicylic acid, sulfapyridine, TNF-α, LPS, phorbol ester, proteasome, AP-1, immunosuppression, inflammatory bowel disease, rheumatoid arthritis, colon cancer cells
- MeSH terms
- Anti-Infective Agents, Anti-Inflammatory Agents, Anti-Inflammatory Agents, Non-Steroidal, Antioxidants, Aspirin, Cells, Cultured, Colonic Diseases, Cystine, Epithelial Cells, Humans, Immunosuppression Therapy, Lipopolysaccharides, Phorbol Esters, Phosphorylation, Plasmids, Proline, Recombinant Proteins, Recombination, Genetic, Sulfasalazine, Sulfapyridine, Thiocarbamates, Transfection, Tumor Necrosis Factor-alpha, Blotting, Western, NF-kappa B, Transcription Factor AP-1, Fluorescent Antibody Technique, Indirect, Mesalamine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review